
AI Is Entering Drug Discovery Just as Investors Question AI Spending: What Biotech's Q4 2026 Disclosures Show
Biotechs are reporting real progress while AI is being built into the work, but the AI funding mood turned cautious in late October. Via News checked company releases and SEC-sourced Incyte figures. The sourced evidence for an AI-biotech link is thin, and we say where.



















